Your browser is no longer supported. Please, upgrade your browser.
Quidel Corporation
Index- P/E6.45 EPS (ttm)21.75 Insider Own1.70% Shs Outstand42.51M Perf Week0.31%
Market Cap6.03B Forward P/E27.53 EPS next Y5.09 Insider Trans-3.58% Shs Float37.47M Perf Month8.99%
Income948.10M PEG0.90 EPS next Q1.20 Inst Own89.10% Short Float15.09% Perf Quarter29.11%
Sales1.86B P/S3.24 EPS this Y971.80% Inst Trans2.65% Short Ratio6.89 Perf Half Y-44.82%
Book/sh35.04 P/B4.00 EPS next Y-41.55% ROA61.30% Target Price146.50 Perf Year-50.38%
Cash/sh22.82 P/C6.14 EPS next 5Y7.20% ROE88.50% 52W Range103.31 - 306.72 Perf YTD-21.98%
Dividend- P/FCF5.93 EPS past 5Y154.30% ROI61.30% 52W High-53.68% Beta-0.04
Dividend %- Quick Ratio3.00 Sales past 5Y53.30% Gross Margin82.50% 52W Low37.52% ATR6.41
Employees1370 Current Ratio3.50 Sales Q/Q114.80% Oper. Margin65.60% RSI (14)60.91 Volatility3.69% 5.20%
OptionableYes Debt/Eq0.00 EPS Q/Q339.30% Profit Margin50.90% Rel Volume0.58 Prev Close140.16
ShortableYes LT Debt/Eq0.00 EarningsAug 05 AMC Payout0.00% Avg Volume820.81K Price142.07
Recom2.50 SMA207.46% SMA5016.00% SMA200-14.39% Volume53,223 Change1.36%
Jan-22-21Upgrade Raymond James Mkt Perform → Outperform $250
May-12-20Downgrade JP Morgan Neutral → Underweight $120 → $158
Mar-26-20Downgrade Barclays Overweight → Equal Weight $90
Oct-23-18Resumed Raymond James Strong Buy $80
Mar-08-18Upgrade Raymond James Outperform → Strong Buy
Jan-22-18Reiterated Barclays Overweight $50 → $60
Jan-04-18Upgrade CL King Neutral → Buy
Sep-19-17Upgrade Piper Jaffray Neutral → Overweight
Jul-18-17Upgrade William Blair Mkt Perform → Outperform
Jul-18-17Upgrade Canaccord Genuity Hold → Buy $25 → $42
Apr-25-17Reiterated Canaccord Genuity Hold $24 → $24.50
Feb-17-17Initiated CL King Neutral
Dec-16-16Downgrade Piper Jaffray Overweight → Neutral
Jun-13-16Upgrade Raymond James Mkt Perform → Outperform
Feb-18-16Reiterated Barclays Overweight $28 → $22
Feb-09-16Downgrade Canaccord Genuity Buy → Hold $22 → $18
Jan-08-16Reiterated Canaccord Genuity Buy $25 → $22
Dec-14-15Downgrade Raymond James Outperform → Mkt Perform
Sep-02-15Initiated Barclays Overweight $28
Jul-31-13Reiterated Canaccord Genuity Buy $30 → $35
Jul-29-21 03:05PM  
Jul-28-21 07:49AM  
Jul-26-21 08:30AM  
Jul-21-21 05:59AM  
Jul-19-21 04:29PM  
Jul-14-21 04:10PM  
Jul-13-21 11:03AM  
Jul-12-21 09:15AM  
Jul-08-21 05:50PM  
Jul-01-21 05:50PM  
Jun-30-21 01:43AM  
Jun-29-21 06:29PM  
Jun-24-21 05:50PM  
Jun-21-21 07:30AM  
Jun-19-21 06:02AM  
Jun-18-21 05:45PM  
Jun-16-21 05:50PM  
Jun-14-21 08:42AM  
Jun-13-21 05:18AM  
Jun-11-21 04:10PM  
Jun-10-21 04:45PM  
Jun-09-21 05:45PM  
Jun-07-21 11:11AM  
May-29-21 06:40AM  
May-24-21 05:10PM  
May-23-21 04:08AM  
May-14-21 04:10PM  
May-07-21 01:58PM  
May-06-21 08:55PM  
May-05-21 08:30PM  
May-04-21 06:00PM  
May-01-21 10:17AM  
Apr-30-21 09:55AM  
Apr-29-21 12:34PM  
Apr-28-21 12:16PM  
Apr-27-21 10:08AM  
Apr-26-21 07:00PM  
Apr-24-21 05:49AM  
Apr-23-21 08:22AM  
Apr-22-21 04:32PM  
Apr-21-21 05:45PM  
Apr-14-21 05:45PM  
Apr-13-21 08:00AM  
Apr-08-21 05:50PM  
Apr-07-21 10:15PM  
Apr-05-21 08:00AM  
Apr-01-21 08:02PM  
Mar-31-21 11:30PM  
Mar-30-21 06:40AM  
Mar-29-21 10:04AM  
Mar-26-21 05:45PM  
Mar-22-21 11:11AM  
Mar-20-21 06:45AM  
Mar-18-21 06:00PM  
Mar-16-21 05:50PM  
Mar-15-21 12:44PM  
Mar-13-21 02:27AM  
Mar-12-21 03:33AM  
Mar-10-21 04:06PM  
Mar-08-21 09:51AM  
Mar-01-21 11:51AM  
Feb-22-21 05:00PM  
Feb-20-21 11:05AM  
Feb-19-21 02:45PM  
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide. It offers Sofia and Sofia 2 fluorescent immunoassay systems; QuickVue, a lateral flow immunoassay products; and InflammaDry and AdenoPlus, a POC products to detect infectious and inflammatory diseases and conditions of the eye. The company also provides Triage MeterPro, a portable testing platform that enables physicians to promote enhanced health outcomes, as well as the detection of certain drugs of abuse; Triage BNP test for use on Beckman Coulter lab analyzers; and Triage TOX drug screen, which provides results for the determination of the presence of drug and/or the major metabolites in urine. In addition, it offers traditional cell lines, specimen collection devices, media, and controls for use in laboratories that culture and test for various human viruses, including respiratory and herpes family viruses; and cell-based products comprising tubes, shell vials, and multi-well plates. Further, the company provides biomarkers, which include clinical and research products for the assessment of osteoporosis and the evaluation of bone resorption/formation; and enzyme linked immunosorbent assays and reagents for the detection of activation products. Additionally, it offers Lyra molecular real-time polymerase chain reaction assays; Solana, an amplification and detection system; and Virena, a wireless cellular data management and surveillance system The company markets its products through distributors and direct sales force for use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail and urgent care clinics, pharmacies, and wellness screening centers. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kroll WernerSVP, R&DJul 01Option Exercise0.00982011,229Jul 02 06:08 PM
Ferenczy William J.SVP, Cardio/Metabolic UnitJun 12Option Exercise0.002,00007,324Jun 16 08:23 PM
Kroll WernerSVP, R&DMay 27Option Exercise0.004,376012,495Jun 01 07:56 PM
WIDDER KENNETH JDirectorMay 16Option Exercise0.00576016,032May 18 08:00 PM
POLAN MARY LAKE PH DDirectorMay 16Option Exercise0.00485025,854May 18 07:59 PM
SLACIK CHARLES PDirectorMay 14Option Exercise0.00734012,199May 14 08:12 PM
SLACIK CHARLES PDirectorMay 13Sale113.261,000113,25811,465May 14 08:12 PM
SLACIK CHARLES PDirectorMay 12Option Exercise0.001,250012,465May 14 08:12 PM
RHOADS ANN DDirectorMay 12Option Exercise0.006240624May 14 08:10 PM
POLAN MARY LAKE PH DDirectorMay 12Option Exercise0.001,040025,369May 14 08:09 PM
ORDONEZ KATHYDirectorMay 12Option Exercise0.001,04002,896May 14 08:08 PM
Michael Edward L.DirectorMay 12Option Exercise0.001,04007,474May 14 08:06 PM
BUECHLER KENNETH FDirectorMay 12Option Exercise0.001,040060,864May 14 08:05 PM
Wilkins Joseph D Jr.DirectorMay 12Option Exercise0.002890289May 14 08:22 PM
WIDDER KENNETH JDirectorMay 12Option Exercise0.001,040015,456May 14 08:19 PM
Strobeck MatthewDirectorMay 12Option Exercise0.001,04004,909May 14 08:15 PM
Ferenczy William J.SVP, Cardio/Metabolic UnitMay 03Option Exercise23.4180318,7986,127May 04 07:45 PM
Ferenczy William J.SVP, Cardio/Metabolic UnitMay 03Sale105.7480384,9095,324May 04 07:45 PM
Ferenczy William J.SVP, Cardio/Metabolic UnitMar 17Option Exercise16.604,60176,39012,506Mar 19 07:55 PM
Ferenczy William J.SVP, Cardio/Metabolic UnitMar 17Sale136.067,4001,006,8375,106Mar 19 07:55 PM
Kroll WernerSVP, R&DFeb 24Sale173.715,283917,7348,119Feb 24 07:53 PM
Kroll WernerSVP, R&DFeb 23Sale166.304,835804,05813,402Feb 24 07:53 PM
Kroll WernerSVP, R&DFeb 22Option Exercise43.5412,784556,67431,021Feb 24 07:53 PM
BRYANT DOUGLAS CPresident & CEOFeb 22Buy165.305,000826,500495,807Feb 22 07:40 PM
Kroll WernerSVP, R&DFeb 22Sale164.1112,7842,097,95518,237Feb 24 07:53 PM
POLAN MARY LAKE PH DDirectorDec 01Sale192.2511,0002,114,79724,329Dec 03 07:32 PM
POLAN MARY LAKE PH DDirectorNov 06Sale284.173,000852,50535,329Nov 06 07:19 PM
SLACIK CHARLES PDirectorNov 05Option Exercise20.824,00983,46715,224Nov 06 07:16 PM
SLACIK CHARLES PDirectorNov 05Sale282.464,0091,132,38811,215Nov 06 07:16 PM
POLAN MARY LAKE PH DDirectorOct 23Option Exercise21.6327,188588,14238,329Oct 27 07:37 PM
POLAN MARY LAKE PH DDirectorOct 12Sale275.8311,7433,239,01511,141Oct 14 07:26 PM
Strobeck MatthewDirectorSep 03Buy155.6340062,25438,145Sep 04 07:09 PM
Strobeck MatthewDirectorSep 02Buy166.657,3001,216,51137,745Sep 04 07:09 PM
BRYANT DOUGLAS CPresident & CEOAug 31Buy174.995,000874,965455,823Sep 01 06:05 PM
Abney Michael Donald Jr.SVP - DistributionAug 20Option Exercise34.142,58288,1439,216Aug 24 12:03 PM
Abney Michael Donald Jr.SVP - DistributionAug 20Sale250.002,582645,5006,634Aug 24 12:03 PM
Abney Michael Donald Jr.SVP - DistributionAug 19Option Exercise35.875,610201,21512,244Aug 24 12:03 PM
Abney Michael Donald Jr.SVP - DistributionAug 19Sale250.005,6101,402,5006,634Aug 24 12:03 PM
BRYANT DOUGLAS CPresident & CEOAug 11Buy234.125,0001,170,600450,823Aug 11 08:38 PM